Panel Discussion: AAV, LNP, and the Implications for In Vivo Delivery Analytical Testing Requirements

Time: 3:15 pm
day: Conference Day Two


  • Generating robust analytical data for your delivery vehicle to bridge the gap between in vitro and in vivo studies
  • Highlighting key analytical challenges for AAV and LNP delivery of gene editing therapies
  • Developing an effective safety assessment to identify toxicities related to the delivery method